Biocryst Pharmaceuticals Overview
Biocryst Pharmaceuticals Discounted Cash Flow
DCF Analysis for BCRX.
Get informed when a big investor buys or sells
+ FollowFair Value
$7.62
Current Fair Value
$7.62
↓ 15.9% Downside
Overvalued by 15.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison